MUNICH, GERMANY, February 1, 2017 -- Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced new automated patch clamp (APC) functionality in Genedata Screener for Ion Channel Screening and a Genedata Ready-to-Run integration with Nanion SyncroPatch 384PE. The package provides seamless data capture and innovative analysis of Nanion's multi-sweep, multi-dose current traces as well as interactive access to the raw traces for visualization and analysis optimization. The Genedata Screener/Nanion SyncroPatch 384PE integration will be demonstrated along with the new functionality at an SLAS2017 tutorial session, one of the Genedata Screener events at SLAS2017. Genedata will present at Booth #541; Nanion Technologies will present at Booth #1311 (Walter E. Washington Convention Center, Washington, DC Feb. 4-8.)
Read full press release here.
DURHAM, N.C., LIVINGSTON, N.J. and MUNICH, GERMANY, July 27, 2016 -- Icagen Acquires Nanion's SyncroPatch384 High-Throughput Electrophysiology Platform -- Entering agreement with Nanion to develop and commercialize innovative ion channel drug discovery solutions - assays for two gene families established
MUNICH, GERMANY, June 28, 2016 -- Nanion Technologies is pleased to announce the opening of a new site in Copenhagen, Denmark. The site contains a fully equipped laboratory and state-of-the-art ion channel high throughput screening platforms, including the SyncroPatch 384/768PE. The new facility within Copenhagen University opens its doors for scientific collaborations, assay development support and product demonstrations.
MUNICH, GERMANY, January 13, 2016 -- Nanion Technologies is pleased to announce that Frank Henrichsen has accepted the position of Director of Global Sales. Frank Henrichsen has a solid technical and commercial track record in life science industry, and is one of the pioneers in the global deployment of automated patch clamp systems in pharmaceutical companies and CROs.